Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating
from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled …

Although cytoreductive surgery (CRS) and hyperthermic perioperative chemotherapy
(HIPEC) have not been shown to be effective by themselves, as a combined treatment they …

Background This was a population-based cohort study to determine the incidence,
prevalence and risk factors for peritoneal carcinomatosis (PC) from colorectal cancer …

Background Peritoneal adhesions are a common complication after abdominal surgery.
They cause small bowel obstruction, female infertility and chronic abdominal pain …

Metastases account for 90% of cancer-related deaths; thus, it is vital to understand the
biology of tumour dissemination. Here, we collected and monitored> 50 patient specimens …

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for patients with
malignant peritoneal mesothelioma has resulted in improved disease control and increased …

Background: Colorectal cancer peritoneal metastasis (CPM) confers an exceptionally poor
prognosis, and traditional treatment involving systemic chemotherapy (SC) is largely …

Background Pseudomyxoma peritonei (PMP) is a clinical malignant syndrome mainly
originating from the appendix, with an incidence of 2–4 per million people. As a rare …

Despite improvements in chemotherapy and radical surgical debulking, peritoneal
carcinomatosis (PC) remains among the most common causes of death from abdominal …

Simple Summary Pseudomyxoma peritonei (PMP) is an uncommon pathology, and its rarity
causes a lack of scientific evidence, precluding the design of a prospective trial. A diagnostic …